Obesity-mediated liver inflammation is also attenuated in Lyz-IFNγR2−/− mice with profoundly reduced intrahepatic levels of IL-12, and in vivo treatment with IL-12 causes insulin resistance by impairing hepatic insulin signaling in wild-type (WT) mice. The gene discussed is IFNGR2; the disease is Insulin resistance.